Bank of Montreal (BMO)
$100.73 -$0.04 (-0.04%) 1:54 AM 12/12/24
NYSE | $USD | Banks - DiversifiedStock Data
-
Market Cap
$76.14B -
Day's Range
$100.85 - $101.48 -
Volume
860,174 -
52 Week Low / High
$76.06 - $104.63 -
PE Ratio
15.25x -
PEG Ratio
0.71 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 4
- Buy
- 8
- Hold
- 0
- Sell
- 0
- Strong Sell
- $90.33
- Target Price
Company News
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Canada's trade deficit narrows in October, surplus with the U.S. shrinks — Dec 5th, 2024
Canada recorded in October a bigger-than-expected trade deficit with the world and its surplus with top trading partner the United States fell to its lowest this year, data showed on Thursday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova — Nov 14th, 2024
Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
-
US FDA approves Merus' therapy to treat lung, pancreatic cancers — Dec 4th, 2024
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday....
-
NWSL sees 6 percent increase in setting new attendance record — Nov 27th, 2024
The NWSL set a new attendance record in 2024, according to a report from Sports Business Journal, as clubs averaged 11,250 fans in attendance, a six percent increase compared to the previous year....
-
Angel City F Claire Emslie agrees to new 2-year deal — Nov 22nd, 2024
Angel City FC forward Claire Emslie agreed to a new two-year contract through the 2026 NWSL season, the team announced Friday....
Portfolio
Comprised of 1 portfolios